• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

RecommendedBeta
Recent
Webcasts
Press releases

Latest research

Trending

Upcoming webcasts

Inderes illustration

Connecting investors and companies

Inderes is a hub connecting investors and listed companies. We are home to over 70 000 investors and 400 Nordic listed companies. Log in to keep up with your favourite companies!

Create an accountLog in
 
OMXHPI-0.15 %
OMXH25+0.13 %
OMXSPI-0.27 %
SPRING+9.70 %
HONBS+8.30 %
ECOUP+5.73 %
NXTMH-3.36 %
SAGCV-3.38 %
EAGLE-5.37 %
 
 

Next up today

Arjo
Balder
HMS Netw
Lifco
Vitec So
Addtech
Bactigua
Xvivo Pe
 
Neste Q2'26 preview: Margin party keeps on running
Research10.07.2026 klo 09.10 by
Petri Gostowski

Neste Q2'26 preview: Margin party keeps on running

Neste will publish its Q2'26 results on Friday, July 24, at around 9:00 am EEST.

Neste
Scanfil Q2'26 preview: Growth engine has been running on two cylinders
Analyst Comment13.07.2026 klo 08.56 by
Antti Viljakainen

Scanfil Q2'26 preview: Growth engine has been running on two cylinders

We expect revenue growth to have also driven a clear improvement in the company's earnings in Q2. We believe the company will reiterate its guidance.

Scanfil
Koskisen: The market situation has remained difficult as expected during Q2
Analyst Comment13.07.2026 klo 08.44 by
Antti Viljakainen

Koskisen: The market situation has remained difficult as expected during Q2

Demand for birch plywood exceeded expectations in Q2, but the high price of logs and weak construction demand are still holding back margins in both units.

Koskisen

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Teleste Extensive Report: More bandwidth built for earnings growth
Extensive research07.07.2026 klo 11.30 by
Atte Riikola, Roni Peuranheimo

Teleste Extensive Report: More bandwidth built for earnings growth

Relative to the earnings growth outlook for the coming years, Teleste's share valuation appears very moderate.

Teleste
Nurminen Logistics Q2'26 preview: Westward bound
Research08.07.2026 klo 08.50 by
Aapeli Pursimo

Nurminen Logistics Q2'26 preview: Westward bound

We significantly lowered our earnings estimates for Nurminen Logistics for the coming years due to last week's profit warning.

Nurminen Logistics
GreenMobility (Investment case): H1 2026, profitability and cash returns proven, H2 to restore the growth trajectory
Research13.07.2026 klo 14.00 by
Michael Friis, Victor Skriver

GreenMobility (Investment case): H1 2026, profitability and cash returns proven, H2 to restore the growth trajectory

In connection with the publication of GreenMobility's H1 2026 interim report and the adjusted 2026 guidance, we have updated our investment case

GreenMobility
Björn Borg extensive report: Well-positioned to keep delivering profitable growth
Extensive research09.07.2026 klo 07.30 by
Lucas Mattsson

Björn Borg extensive report: Well-positioned to keep delivering profitable growth

In our view, Björn Borg has made good progress executing its strategy of expanding its core product categories and own e-commerce channel, which we expect to keep driving profitable growth.

Björn Borg
Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading
Analyst Comment13.07.2026 klo 08.45 by
Michael Friis

Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading

Ascelia Pharma provided a follow-up update yesterday, July 12, on the Complete Response Letter received on July 3. This is the first substantive detail the company has disclosed on the nature of the FDA's clinical concerns since the CRL, and it meaningfully narrows, though does not close, the range of scenarios we flagged in our July 3 note.

Ascelia Pharma
Digital Workforce: Acquisition well aligned with strategy
Research02.07.2026 klo 09.15 by
Joni Grönqvist

Digital Workforce: Acquisition well aligned with strategy

Digital Workforce announced yesterday that it has acquired AI agent capabilities, which aligns well with the company's strategy.

Digital Workforce
Regulatory press release02.07.2026 klo 12.45

Nurminen Logistics Plc: Inside information, profit warning: Outlook 2026 - Net sales to remain at or slightly below 2025 level. Comp. EBITA to decline clearly from 2025 while remaining at a good level

Nurminen Logistics
Regulatory press release01.07.2026 klo 16.01

Inside information, profit warning: Lemonsoft lowers net sales growth forecast for 2026, profitability forecast remains unchanged

Lemonsoft
Regulatory press release17.06.2026 klo 17.30

Netum Group Plc: Inside information, profit warning: Netum lowers its revenue and profitability guidance for 2026

Netum Group
Regulatory press release17.06.2026 klo 17.10

Inside Information: Profit Warning; Solwers withdraws its 2026 outlook and will not meet the current covenant condition

Solwers
Regulatory press release16.06.2026 klo 15.35

Inside information, profit warning: Kreate Group Plc raises its guidance for 2026: revenue EUR 600–650 million and EBITA EUR 21–26 million

Kreate Group
Bioretec Extensive Report: Signs of recovery in growth fracture
Extensive research25.06.2026 klo 14.13 by
Antti Siltanen

Bioretec Extensive Report: Signs of recovery in growth fracture

We expect the company to show clear signs of growth this year.

Bioretec
Fiskars Extensive Report: Vita's turnaround is already baked into the price
Extensive research24.06.2026 klo 12.33 by
Rauli Juva

Fiskars Extensive Report: Vita's turnaround is already baked into the price

Fiskars is currently a brand house divided into two independent segments (Fiskars and Vita).

Fiskars
Spinnova: Strategy on track, but risk/reward remains murky
Research30.06.2026 klo 08.51 by
Antti Viljakainen, Kaisa Vanha-Perttula

Spinnova: Strategy on track, but risk/reward remains murky

We have not made any material changes to our forecasts, even though Spinnova appears to have advanced its strategy both in terms of assembling a cooperation consortium around the technology and verifying the reduction in the technology's production and investment costs.

Spinnova
Biohit: Sold on summer sale
Research29.06.2026 klo 09.00 by
Antti Siltanen

Biohit: Sold on summer sale

The stock's valuation has fallen to a rather low level.

Biohit
Alexandria Extensive Report: The strategy is taking the company in the right direction
Extensive research22.06.2026 klo 10.24 by
Sauli Vilén

Alexandria Extensive Report: The strategy is taking the company in the right direction

Alexandria's valuation is cheap, and the potential success of asset management offers a potential bonus.

Alexandria Group
Talenom extensive report: Finland stands firm, international turnaround is key
Extensive research18.06.2026 klo 17.39 by
Juha Kinnunen

Talenom extensive report: Finland stands firm, international turnaround is key

Talenom's Finnish core business continues to reliably generate strong cash flow, but investors doubt the sensibility of international growth.

Talenom

Latest research

Neste Q2'26 preview: Margin party keeps on running
Accumulate
Neste
10.07.2026
Björn Borg extensive report: Well-positioned to keep delivering profitable growth
Accumulate
Björn Borg
09.07.2026
Nurminen Logistics Q2'26 preview: Westward bound
Accumulate
Nurminen Logistics
08.07.2026
Teleste Extensive Report: More bandwidth built for earnings growth
Accumulate
Teleste
07.07.2026
Digital Workforce: Acquisition well aligned with strategy
Buy
Digital Workforce
02.07.2026
View all

Trending

Nordea Q2'26 preview: Has net interest income bottomed out yet?
07.07.2026 Analyst Comment
Neste Q2'26 preview: Margin party keeps on running
10.07.2026 Research
S-Pankki julkaisi ostotarjouksen OmaSp:n osakkeista
09.07.2026 Analyst Comment
Admicom Q2'26: Arvostustaso on historiallisen matala
09.07.2026 Research
OmaSp: Suosittelemme omistajia hyväksymään tarjouksen
09.07.2026 Research

Upcoming webcasts

Elisa, Audiocast, Q2'26
Tomorrow at 12.00 Elisa
Verkkokauppa.com Oyj, Q2'26
16.07.2026 klo 10.00 Verkkokauppa.com
Fiskars, Webcast, Q2'26
16.07.2026 klo 11.00 Fiskars
Oriola, Webcast, Q2'26
17.07.2026 klo 10.00 Oriola
Kemira Oyj, Webcast, Q2'26
17.07.2026 klo 10.00 Kemira
Show all